KaySer © DHA – November 21 World COPD Day ERCİYES University (ERU) The event was held at the Medical Faculty Hospital.
A booth was installed at the entrance of the Gevher Nesibe Hospital where citizens were subjected to a free respiratory function test within the scope of activities performed by the Turkish Thoracic Society. Department of Thoracic and Cardiovascular Surgery, ERU. Dr. Inci Gülmez said that one in five patients over the age of 40 had COPD and only one out of 10 COPD patients had consultations with the doctor.
Professor Dr. Gulmez said about COPD:
Nowadays, COPD accounts for 5.5% of deaths for the third time in the world. Turkey's respiratory disease is the third most common cause of death, accounting for 61.5% of chronic obstructive pulmonary disease deaths. The fact that society does not have sufficient knowledge of chronic obstructive pulmonary disease makes early diagnosis and effective treatment of disease difficult. The most common risk factor for the development of chronic obstructive pulmonary disease is tobacco smoke. Smokers do not drink alcohol and have more respiratory symptoms than people with high respiratory function and COPD mortality. Other types of tobacco use (pipes, cigars, water cigarettes) and environmental tobacco smoke also cause COPD. The role of genetic risk factors in the development of chronic obstructive pulmonary disease remains to be elucidated. However, the role of genetic risk factors in the use of smokable workplaces, especially biomass (wood, feces, roots, etc.), secondary to indoor air pollution and health inequalities Important environmental hazards are known to be used. The importance of physical activity, which is increasingly emphasized in recent years, is considered a risk factor. COPD is a preventable and preventable disease. The first job a patient with chronic obstructive pulmonary disease should do is to talk to a doctor and quit smoking. Avoiding the delivery and application of physical activity as well as the administration of other harmful dust and smoke, influenza and pneumococcal vaccines, and inhalation medications are important steps in both disease progression and disease progression and poor outcome prevention.